Merck Presents New Phase 3 Data for Investigationa...
Category : Clinical Trial Update 16 October 2025Merck (known as MSD outside the U.S. and Canada) presented additional results from two Phase 3 clini...
Merck (known as MSD outside the U.S. and Canada) presented additional results from two Phase 3 clini...
Clover Biopharmaceuticals, Ltd., a global commercial-stage biotechnology company focused on developi...
Boehringer Ingelheim and Click Therapeutics presented data from the pivotal phase III CONVOKE study...
CalciMedica Inc., a clinical-stage biopharmaceutical company developing CRAC channel inhibition ther...
Ascletis Pharma Inc. (HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agoni...